title: Myasthenia gravis following IFN-alpha-2a treatment.
authors.affiliation: Uludag University School of Medicine, Department of Neurology, Bursa, Turkey.
authors.forename: I
authors.initials: I
authors.lastname: Bora
authors.forename: N
authors.initials: N
authors.lastname: Karli
authors.forename: M
authors.initials: M
authors.lastname: Bakar
authors.forename: M
authors.initials: M
authors.lastname: Zarifoğlu
authors.forename: F
authors.initials: F
authors.lastname: Turan
authors.forename: E
authors.initials: E
authors.lastname: Oğul
mesh_terms: D015551:Autoimmunity / Q000187:drug effects*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects* / Q000276:immunology; D008297:Male; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000139:chemically induced* / Q000276:immunology; D011994:Recombinant Proteins
chemical_list: D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins